# A Study to Investigate the Contraceptive Efficacy and Safety of a Subdermal Etonogestrel Implant (Implanon®)(P06473)(COMPLETED)

> **NCT00725413** · PHASE4 · COMPLETED · sponsor: **Organon and Co** · enrollment: 210 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** etonogestrel implant (Implanon)

## Key facts

- **NCT ID:** NCT00725413
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-11
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2022-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00725413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00725413, "A Study to Investigate the Contraceptive Efficacy and Safety of a Subdermal Etonogestrel Implant (Implanon®)(P06473)(COMPLETED)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00725413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*